MAX汽车工业每日三倍做空ETN CARD 深 沪
已收盘 05-08 16:00:00 美东时间
2.7225
-0.043
-1.55%
华盛通- 最 高2.74
- 今 开2.73
- 成交量 3705股
- 最 低 2.69
- 昨 收 2.7654
- 总市值 163.35万
- 52周最高 4.61
- 市盈率 静 --
- 换手率 0.62%
- 52周最低 2.29
- 委 比 0.00%
- 总股本 60.00万
- 历史最高 36.23
- 量 比 0.23
- 振 幅 1.81%
- 历史最低 2.29
- 每 手 1
- 风险率 0.62%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Ironwood Capital flags environmental services M&A consolidation driven by infrastructure, regulation
Ironwood Capital flags environmental services M&A consolidation driven by infrastructure, regulation Ironwood Capital Management analysis flagged accelerating consolidation in environmental services, with strategic buyers and private equity pursuing scale, route density, broader service offerings, a
05-07 21:38
BRIEF-Citigroup CEO Says Return Levels Over Medium Term Can Be Achieved Organically
BRIEF-Citigroup CEO Says Return Levels Over Medium Term Can Be Achieved Organically May 7 (Reuters) - Citigroup Inc C.N : CITIGROUP CEO JANE FRASER SAYS WE WILL STEADILY SCALE WEALTH BY CONTINUING TO INVEST IN ADVISORS, DATA AND TECHNOLOGY, INCLUDING AI TO IMPROVE PRODUCTIVITY CITIGROUP CEO SAYS AI
05-07 20:57
Transcript: Revolve Gr Q1 2026 Earnings Conference Call
Revolve Gr (NYSE:RVLV) released first-quarter financial results and hosted an e...
05-06 05:29
INSTANT VIEW-US growth picks up; PCE inflation is higher but in line with expectations
INSTANT VIEW-US growth picks up; PCE inflation is higher but in line with expectations NEW YORK, April 30 (Reuters) - U.S. economic growth picked up in the first quarter on a rebound in government spending, but the increase is likely temporary as the war with Iran drives up gasoline prices and squee
04-30 21:26
BRIEF-Chengdu Kanghong: US FDA Approves KHN921 Clinical Trial For Hypertrophic Cardiomyopathy Treatment
BRIEF-Chengdu Kanghong: US FDA Approves KHN921 Clinical Trial For Hypertrophic Cardiomyopathy Treatment April 19 (Reuters) - Chengdu Kanghong Pharmaceutical Group Co Ltd 002773.SZ : US FDA APPROVES CLINICAL TRIAL OF KHN921 FOR HYPERTROPHIC CARDIOMYOPATHY TREATMENT Source text Further company coverag
04-19 17:11
J&J first-quarter profit beats on cancer drug Darzalex demand; raises 2026 outlook
J&J first-quarter profit beats on cancer drug Darzalex demand; raises 2026 outlook Overview U.S. healthcare conglomerate's Q1 revenue rose 9.9%, beating analyst expectations Adjusted EPS for Q1 beat analyst expectations Company raised full-year 2026 sales and adjusted EPS guidance Johnson & Johnson
04-14 18:30
Tesco partners with Adobe to ramp up AI‑driven personalised marketing
Tesco partners with Adobe to ramp up AI‑driven personalised marketing LONDON, April 13 (Reuters) - Tesco, Britain's biggest food retailer, has partnered with U.S. software group Adobe to deepen its use of artificial intelligence in analysing customer data, aiming to boost sales through more personal
04-13 20:12
ECARX explores acquiring DreamSmart minority stake, FlyMe OS IP assets
ECARX explores acquiring DreamSmart minority stake, FlyMe OS IP assets ECARX outlined preliminary plan to acquire minority stake and selected intellectual property assets tied to FlyMe OS from affiliate DreamSmart. Consideration may combine cash with ECARX securities. Third-party debt financing may
04-08 17:00
Merck Lowered Terns Pharmaceuticals Offer Price After Trial Data Review
Merck cuts Terns deal price after TERN-701 data review, while maintaining interest amid competition and CML treatment comparisons.
04-08 02:28
SBI Cards Receives ESG Score of 71 from SEBI-Registered Rater
SBI Cards & Payment Services Ltd ( ($IN:SBICARD) ) has shared an update. SB...
04-07 13:14
